Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XENE | SYRE | APLS | ||
| Company | Xenon Pharmaceuticals Inc | Spyre Therapeutics Inc | Apellis Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 55.42 | 69.83 | 40.94 | ||
| High | 55.56 | 72.07 | 40.94 | ||
| Low | 54.31 | 68.43 | 40.90 | ||
| Latest | 55.24 | 69.67 | 40.94 | ||
| Change | -0.17 | +0.43 | unch | ||
| % Change | -0.31% | +0.62% | unch | ||
| Volume | 601,400 | 601,200 | 2,079,600 | ||
| 20-Day Average Volume | 913,430 | 1,391,375 | 10,185,180 | ||
| Previous Close | 55.41 | 69.24 | 40.94 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 57.32 | 59.52 | 38.38 | ||
| 20-Day Raw Stochastic | 25.43% | 82.35% | 99.96% | ||
| 20-Day Relative Strength | 51.96 | 71.57 | 82.88 | ||
| Weighted Alpha | +42.38 | +351.85 | +25.79 | ||
| Today's Opinion | 80% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 80% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.47% since 04/17/26 | -4.57% since 04/17/26 | +0.10% since 04/17/26 | ||
| Low | 54.31 on 04/24/26 | 68.32 on 04/23/26 | 40.86 on 04/20/26 | ||
| High | 59.68 on 04/20/26 | 74.84 on 04/21/26 | 40.94 on 04/24/26 | ||
| 1-Month | |||||
| %Chg | +3.48% since 03/24/26 | +65.02% since 03/24/26 | +137.61% since 03/24/26 | ||
| Low | 53.62 on 03/30/26 | 42.68 on 03/25/26 | 16.83 on 03/30/26 | ||
| High | 59.99 on 04/14/26 | 75.00 on 04/13/26 | 40.95 on 04/17/26 | ||
| 3-Month | |||||
| %Chg | +32.28% since 01/23/26 | +117.48% since 01/23/26 | +88.23% since 01/23/26 | ||
| Low | 40.29 on 02/05/26 | 30.92 on 02/04/26 | 16.83 on 03/30/26 | ||
| High | 63.95 on 03/10/26 | 75.00 on 04/13/26 | 40.95 on 04/17/26 | ||
| 6-Month | |||||
| %Chg | +35.53% since 10/24/25 | +198.12% since 10/24/25 | +45.33% since 10/24/25 | ||
| Low | 37.23 on 11/07/25 | 21.15 on 11/07/25 | 16.83 on 03/30/26 | ||
| High | 63.95 on 03/10/26 | 75.00 on 04/13/26 | 40.95 on 04/17/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,338,559 | 5,488,881 | 5,233,360 | ||
| Shares Outstanding, K | 96,643 | 78,784 | 127,830 | ||
| Annual Sales | 7,500,000 | 0 | 1,003,780,000 | ||
| Annual Net Income | -345,910,000 | -155,200,000 | 22,390,000 | ||
| Last Quarter Sales | 0 | 0 | 199,910,000 | ||
| Last Quarter Net Income | -105,260,000 | -62,530,000 | -58,950,000 | ||
| 60-Month Beta | 0.74 | 2.93 | -0.19 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.31 on 02/26/26 | -0.70 on 02/19/26 | -0.47 on 02/24/26 | ||
| Latest Earnings Date | 05/11/26 | 05/14/26 | 05/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 314.92 | ||